Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin

Bone Marrow Transplantation

Volumn 31, Issue 12, 2003, Pages 1165-1168

  Ikegame, K ^a   Mukouchi, C ^a   Kunitomi, A ^b   Konaka, Y ^b   Kawakami, M ^a   Nishida, S ^a   Taniguchi, Y ^a   Fujioka, T ^a   Masuda, T ^a   Murakami, M ^a   Hosen, N ^a   Kim, E H ^a   Tsuboi, A ^a   Oji, Y ^c   Oka, Y ^a   Sugiyama, H ^c   Kawase, I ^a   Ogawa, H ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kitano Hospital   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

bcr abl positive acute leukemia; Graft versus host disease; HLA mismatched BMT; Imatinib

Indexed keywords

ASPARAGINASE; BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IDARUBICIN; IMATINIB; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CELL LINEAGE; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HLA MATCHING; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA REMISSION; PRIORITY JOURNAL; RELATIVE; SKIN; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; FAMILY; FEMALE; GENES, ABL; GRAFT VS HOST DISEASE; HAPLOTYPES; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MIXED-CELL; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PEDIGREE; PIPERAZINES; PYRIMIDINES; TACROLIMUS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 10744231083     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704064     Document Type: Article

References (13)

1. Henslee-Downey PJ, Abhyankar SH, Parrish RS et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864-3872.
2. Aversa F, Tabilio F, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186-1193.
3. Marmont A, Horowitz M, Gale R et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
4. Ogawa H, Soma T, Hosen N et al. Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. Transplantation 2002; 74: 236-243.
5. Ikegame K, Tanji Y, Kitai N et al. Successful treatment of refractory T cell acute lymphoblastic leukemia by the unmanupulated stem cell transplantation from an HLA 3 loci mismatched (haploidentical) sibling. Bone Marrow Transplant (in press).
6. Ogawa H, Tsuboi A, Oji Y et al. Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogeneic bone marrow transplantation: importance of the monitoring of minimal residual disease by WT1 assay. Bone Marrow Transplant 1998; 21: 525-527.
7. Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia. Blood 1992; 79: 3067-3070.
8. Singhal S, Powles R, Henslee-Downey PJ et al. Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia. Bone Marrow Transplant 2002; 29: 291-295.
9. Ottmann OG, Druker BJ, Sawyers CL et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002; 100: 1965-1971.
10. Guinan EC, Boussiotis VA, Neuberg D et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 1999; 340: 1704-1714.
11. Burlingham W, Railer A, Heisey D et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplantation sibling donors. N Engl J Med 1998; 339: 1657-1664.
12. Oh H, Zhang M-J, Akiyama H et al. Comparison of graft-versus-host disease (GVHD) and survival in different ethnic populations: collaborative study by the Japan Adult Leukemia Study Group (JALSG) and the International Bone Marrow Transplant Registry (IBMTR). Blood 2002; 100: 418 (Abstract 1621).
13. Morishima Y, Morishita Y, Tanimoto M et al. Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group. Blood 1989; 74: 2252-2256.